Dr Peter Fahmy Interventional and Structural Cardiologist MBChB, PhD, FRACP, FCSANZ
Go to Research Review Video to view his presentation at this link: TAVI for your AS Patients: Treating low-surgical risk
Educational Series: Pharmacological prevention and management of heart failure a consensus update
This publication is an educational resource summarising changes in recommendations for the management of stable heart failure, as outlined in a recent Australian Consensus Statement. Commentary by Prof Andrew Sindone.
Includes:
- treatments to prevent or delay the development of heart failure in patients with diabetic kidney disease
- the wider and earlier use of an angiotensin receptor neprilysin inhibitor (ARNI) and SGLT2 inhibitor in those with established heart failure with reduced ejection fraction
- additional therapies for those with heart failure with mildly reduced or preserved ejection fractions.
Download the pdf here: Educational Series: Pharmacological prevention and management of heart failure a consensus update with commentary by Prof Andrew Sindone
Download the CSANZ APP
The CSANZ App has been designed for members to access information, network and collaborate.
The App provides members with a range of information, career enhancing and engagement tools including:
- Engagement and discussion forums
- Guidelines and position statements
- Heart Lung and Circulation Journal
- Cardiology and Member News
- Education and Career Resources
- Scientific Meeting Presentations
- Membership information and billing
CSANZ-Ed: Exertional breathlessness is one of the commonest symptoms leading to visits to a cardiologist.
Exertional breathlessness is one of the commonest symptoms leading to visits to a cardiologist. Among the myriad of causes of breathlessness, pulmonary hypertension (PH) is important and frequently under-recognised.
Our latest article on this subject was led by Dr Pyi Naing FRACP, published in the Internal Medical Journal (IMJ) (http://dx.doi.org/10.1111/imj.15860), summarises the new WHO definition, where PH is defined as a mean pulmonary artery pressure (mPAP) > 20mmHg. This corresponds to a peak PAP >30mmHg, with this systolic pressure threshold confirmed using the NEDA database.
In order to improve recognition and diagnosis, particularly in remote and rural areas where health care resources are scarce, the article proposes a new and simple method of screening for PH. This is summarised in the figure below, the central illustration of the article. For patients presenting with exertional breathlessness, initial screening for heart and lung disease is recommended, and the result of echocardiography may then indicate the presence of PH. If PH is present, left heart disease needs to be considered and treated if present. Similarly, lung disease needs to be considered and treated if present. Importantly, if left heart or lung disease is not identified despite the presence of PH, further investigation is warranted including referral of appropriate patients to a multidisciplinary PH team.
This simple triage approach may assist, particularly in remote and rural communities, in identifying which patients are most suitable for specialist referral.
Reference: https://doi.org/10.1111/imj.15860
”Pulmonary hypertension in remote and disadvantaged population: overcoming unique challenges for improved outcomes” published in Internal Medical Journal
Authors: Naing, P., Kangaharan, N,, Scalia G., Strange G., Playford D.
Australia Day Awards 2023 – Congratulations!
We are very proud to announce the following Australia Day 2023 Honour List Awards to two of our members.
*Prof Clara Chow AM, Immediate Past President, FCSANZ has been awarded a Member of the Order of Australia, (AM) for her significant service to medicine as a cardiologist, and to research.
*Prof Gemma Figtree AM, FCSANZ, also awarded a Member of the Order of Australia (AM) for her significant service to medicine in the field of cardiology.
View a message of congratulations from CSANZ President, Prof Stephen Nicholls including a brief outline of the fabulous work these two women in cardiology have achieved thus far.
Congratulations to you both!
Cardiology Research Review: Issue 150, with commentary by Dr Adam Nelson
In this issue:
- Concealed cardiomyopathy in autopsy- inconclusive SCD
- Telehealth cardiology pharmacist clinic improves treatment adherence after PCI
- Do risk factors for adverse HCM outcomes differ between sexes?
- Fully automated characterisation of vulnerable plaque features on cardiac CT
- Catheter ablation in patients with AF and HFpEF
- Risk prediction for LAAT in patients with AF
- Are priority 1 RHD patients in Central Australia managed according to guidelines?
- Prevalence of coronary artery anomalies in young SCD victims
- Efficacy and safety of PCI in the elderly Next-day discharge following TAVI
- Why don’t patients with STEMI call an ambulance?
- Polygenic risk score predicts AF recurrence after catheter ablation
Call for Papers – Heart, Lung and Circulation Special Issue: Cardio-Oncology
CALL FOR PAPERS Heart, Lung and Circulation Special Issue: Cardio-Oncology The 2023 Special edition of Heart, Lung and Circulation will examine the emerging discipline of cardio-oncology.
Download pdf and read more (pdf)
Prestigious Anitschkow Prize Awarded to Prof Stephen Nicholls
Congratulations to CSANZ Chair, Prof Stephen Nicholls for winning the prestigious 2023 Anitschkow Prize of the European Atherosclerosis Society (EAS).
The Anitschkow Prize is the most prestigious distinction in atherosclerosis research, named after Nikolai Anitschkow who performed the first foundational study, feeding rabbits a cholesterol rich diet and observing the formation of plaques in the aortic wall.
This award recognises Prof Nicholls’ outstanding contributions to atherosclerosis, cardiometabolic disease and preventive cardiology Including elucidating the factors influencing the functionality of high-density lipoproteins; understanding the factors influencing plaque progression and regression; as well as leadership of clinical trials of novel cardioprotective therapies.
Prof Nicholls will receive the Anitschkow Medal and is invited to present the Anitschkow Lecture at the Opening Ceremony of the #EASCongress2023 in Manheim Germany, 21 May 2023.
Important reminder to use Nicotine and Smoking Cessation Support MBS Item numbers
After recent review of access to the Nicotine and Smoking Cessation MBS item numbers it was found that very few medical professionals are using these item numbers. (Access was extended in July 2022 until December 2023).
The Cancer Council Australia has asked for our support for members to utilise these item numbers so that they are not deleted after December 2023.
They include face to face consultations, video and phone consults for nicotine and smoking cessation counselling services – see links below:
Face-to-face: – MBS items 93680, 93681, 93682, 93683, 93684 and 93685.
Videoconference: – MBS items 93690, 93691, 93692, 93693, 93694 and 93695.
Telephone: – MBS items 93700, 93701, 93702, 93703, 93704 and 93705.
For more information and support to conduct nicotine and smoking cessation counselling please refer to the RACGP resources at this link below:
Clinical Resources and Guidelines supporting smoking cessation